Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOβLEI Study
2024-511719-40-00Phase 4Authorised
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ampicillin and ceftriaxone in Enterococcus faecalis endocarditis (2 arms), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Treatment failure (primary). Planned start Jul 2024; status: authorised.
02
Drugs
ampicillinceftriaxone
03
Conditions
Enterococcus faecalis endocarditis
Beyond the preview
Go deeper on 2024-511719-40-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511719-40-00.